Compound class:
Synthetic organic
Comment: This compound is an inhibitor of EGFR with double mutations at L858R (activating mutation) and T790M (gatekeeper resistance mutation) [1]. It was designed to combat advanced tumours that are driven by this mutated kinase, whilst sparing function of the wild type EGFR.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Although the selectivity of compound 52 for EGFRL858R/T790M compared to WT EGFR is low in an enzymatic activity assay (1.7-fold), its selectivity is increased in model cells lines [1]. Compound 52 produces an antitumour effect in xenograft models of EGFRL858R/T790M-driven cancer. |
Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|